Methazolamide
- Product NDC
- 68151-3110
- 11-digit product format
- 681513110
- Labeler code
- 68151
- Product ID
- 68151-3110_e191b251-c4c0-46c6-bbb2-710f51a3368e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- methazolamide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Carilion Materials Management
- Application
- ANDA040062
- Marketing category
- ANDA
- Marketing start
- 2010-06-22
- Marketing end
- 0000-00-00
- Substance
- METHAZOLAMIDE
- Active strength
- 50 mg/1
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a1f610d4-6674-3a87-200e-f2590485d943 | Product name | 3 | 20231221 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68151-3110-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-73c9-f424-e053-dadaa90a57ce | METHAZOLAMIDE TABLETS USP 25 mg and 50 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68151-3110-0 | Methazolamide | 1 in 1 PACKAGE | TABLET | 1 | 2 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| METHAZOLAMIDE | ACTIVE INGREDIENT | W733B0S9SD | METHAZOLAMIDE TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| METHAZOLAMIDE | ACTIVE MOIETY | W733B0S9SD | METHAZOLAMIDE TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE | INACTIVE INGREDIENT | O7TSZ97GEP | METHAZOLAMIDE TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | METHAZOLAMIDE TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | METHAZOLAMIDE TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | METHAZOLAMIDE TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | METHAZOLAMIDE TABLET [CARILION MATERIALS MANAGEMENT] | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68151-3110 | METHAZOLAMIDE TABLET [CARILION MATERIALS MANAGEMENT] | 2 | Legacy NDC, 1 package rows | 20140815_4311658f-8f74-47ad-b38b-17ffa5cdb72f.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197940 | methazolAMIDE 50 MG Oral Tablet | PSN | 4311658f-8f74-47ad-b38b-17ffa5cdb72f | 2 |
| 197940 | methazolamide 50 MG Oral Tablet | SCD | 4311658f-8f74-47ad-b38b-17ffa5cdb72f | 2 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 68151-3110-0 | 68151311000 | 1 in 1 PACKAGE | Historical |